{"id":51,"date":"2011-05-17T09:16:34","date_gmt":"2011-05-17T13:16:34","guid":{"rendered":"https:\/\/retinacanada.com\/en?page_id=51"},"modified":"2011-05-17T09:16:34","modified_gmt":"2011-05-17T13:16:34","slug":"applications","status":"publish","type":"page","link":"https:\/\/retinacanada.com\/en\/?page_id=51","title":{"rendered":"Clinical Research Grant 2012"},"content":{"rendered":"

Congratulations to our Clinical Research Grant Winners<\/strong>
\nThe Retina Foundation of Canada is pleased to announce the winners of its Clinical Research Grant.
\nDr. Flavio Rezende<\/strong>
\nUniversit\u00e9 de Montreal
\n\u201cVitreous Lipidomics in Exudative Age-Related Macular Degeneration\u201d
\nDr. Elvis Ojaimi
\n<\/strong>University of Toronto
\n\u201cRanibizumab for Diabetic Macular Edema: \u00a0Determinants for Treatment Response\u201d
\nEach will receive a grant of $5000 to help them further research in the field of retina disease.
\n<\/p>\n

\n

Coming Soon…<\/h4>\n
The board of directors has asked the Medical Advisory committee to consider funding the following in 2013:<\/div>\n
\n
    \n
  1. A clinical fellowship grant<\/li>\n
  2. An equipment grant for Northern Ophthalmology<\/li>\n<\/ol>\n<\/div>\n
    <\/div>\n
    Details to follow, to be updated on this website.<\/div>\n
    \n

    Below are the details from the 2012 Clinical Research Grant<\/strong>.
    \n 
    \nSPONSOR<\/strong>:
    \nRetina Foundation of Canada (www.retinacanada.com<\/a>)
    \nPROGRAMME:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/strong>
    \nJunior Investigator, Clinical Retina Research Grant.
    \nRESEARCH AREA:<\/strong>
    \nThe mission of the Retina Foundation of Canada is to cure retina disease and preserve vision.
    \nThe grant is to support innovative clinical research in the field of retina disease with an aim of fulfilling the mandate of the Foundation.
    \nAMOUNT:<\/strong>
    \nMaximum of $5000, single disbursement.\u00a0 Two individual awards will be granted.
    \nAPPLICATION DEADLINE:<\/strong>
    \nMarch 1, 2012
    \nADDITIONAL INFORMATION:<\/strong><\/p>\n